Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Cash flows from operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 73,697 $ (139,616) $ (281,704)
Net loss (income) from discontinued operations (3,902) 141,410 335,984
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 65,121 65,955 65,333
Amortization 14,042 13,786 11,593
Amortization of deferred financing costs and original issue discount 2,031 1,907 2,515
Debt extinguishment costs 0 21,166 22,658
Foreign currency exchange loss (gain) 978 4,716 (5,264)
Pension and postretirement healthcare (benefit) expense (1,015) (302) 416
Pension and postretirement healthcare benefit funding 0 0 (3,264)
Deferred income tax (benefit) provision 1,652 4,548 (60,060)
Net loss on asset disposals 3,594 5,666 4,722
Stock compensation 20,632 31,838 17,194
Equity in net income from affiliated companies (27,725) (27,737) (21,065)
Dividends received from affiliated companies 35,000 35,000 40,000
Other, net (1,645) (2,930) (3,478)
Working capital changes that provided (used) cash, excluding the effect of acquisitions and dispositions:      
Receivables 5,503 (33,476) 6,971
Inventories 9,902 631 (2,976)
Prepaids and other current assets 5 (7,827) (1,359)
Accounts payable (10,127) 10,006 6,868
Accrued liabilities (7,448) 12,597 5,015
Net cash provided by operating activities, continuing operations 180,295 137,338 140,099
Net cash provided by (used in) operating activities, discontinued operations 6,311 (7,420) 83,499
Net cash provided by operating activities 186,606 129,918 223,598
Cash flows from investing activities:      
Purchases of property, plant and equipment (58,870) (60,045) (54,837)
Proceeds from business divestitures, net of cash 0 978,449 624,256
Payments for business divestiture (3,744) 0 0
Proceeds from sale of assets 0 0 2,375
Business combinations, net of cash acquired (488) (42,639) 0
Other, net 81 (12) 0
Net cash (used in) provided by investing activities, continuing operations (63,021) 875,753 571,794
Net cash used in investing activities, discontinued operations 0 (40,021) (20,322)
Net cash (used in) provided by investing activities (63,021) 835,732 551,472
Cash flows from financing activities:      
Draw down of revolving credit facilities 0 0 126,500
Repayments of revolving credit facilities 0 0 (126,500)
Issuance of long-term debt, net of original issue discount and financing fees 0 897,750 640,340
Debt issuance costs 0 (1,293) (8,987)
Repayments of long-term debt (9,000) (1,430,863) (1,091,134)
Debt prepayment fees 0 (8,481) (10,550)
Proceeds from financing obligation 0 16,005 0
Dividends paid to stockholders 0 435,593 243,749
Repurchases of common shares (136,741) 0 (2,059)
Tax withholdings on equity award vesting (332) (1,470) (2,539)
Proceeds from stock options exercised 611 746 373
Repayments of financing obligation (2,692) (1,435) 0
Other, net (32) 1,545 (1,875)
Net cash used in financing activities, continuing operations (148,186) (963,089) (720,180)
Net cash used in financing activities, discontinued operations 0 (1,144) (2,640)
Net cash used in financing activities (148,186) (964,233) (722,820)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (5,368) 2,253 11,052
Net change in cash, cash equivalents and restricted cash (29,969) 3,670 63,302
Cash, cash equivalents and restricted cash at beginning of period 140,889 137,219 73,917
Cash, cash equivalents and restricted cash at end of period 110,920 140,889 137,219
Less: cash, cash equivalents and restricted cash of discontinued operations 0 0 (22,202)
Cash, cash equivalents and restricted cash at end of period of continuing operations $ 110,920 $ 140,889 $ 115,017